Table 3 Mean laboratory results during the study period—comparison between the two study groups (2866 participants)
From: HbA1C variability among type 2 diabetic patients: a retrospective cohort study
Variable | HbA1C variability (N = 632) | No HbA1C variability (N = 2234) | p value |
|---|---|---|---|
Glucose level in the blood (mg/dl) | 191 ± 41.0 | 150.2 ± 31.9 | < 0.001 |
LDL level (mg/dl) | 98.1 ± 24.6 | 90.8 ± 20.2 | < 0.001 |
Triglyceride level (mg/dl) | 185 ± 107.0 | 150.8 ± 65.0 | < 0.001 |
HDL levels (mg/dl) | 45.0 ± 10.5 | 47.4 ± 10.7 | < 0.001 |
Nephropathy (by microalbumin/creatinine ratio) | 65.3% (417) | 47.0% (1051) | < 0.001 |
HbA1C levels (mean value) | 9.1 ± 1.2 | 7.4 ± 0.9 | < 0.001 |
HbA1C levels (median) | 8.9 ± 1.4 | 7.4 ± 0.9 | < 0.001 |
HbA1C counts during study period | 20.5 ± 6.8 | 21.09 ± 6.8 | 0.057 |